Ajooni Biotech

Ajooni Biotech FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Ajooni Biotech (AJOONI.NS) as of Oct 19, 2026 is -537.53 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -610.53 % — a change of -11.96% (higher).

FCF Conversion

-537.53 %

YoY

-11.96%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Ajooni Biotech is 2026 -537.53 % . FCF Conversion Rate (FCF/EBITDA) of Ajooni Biotech was 2025 -610.53 % . It decreases by -11.96% higher compared to the previous year.

The Ajooni Biotech FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
-1,265.88 INR
Jan 1, 2020
-1,668.28 INR
Jan 1, 2021
-635.64 INR
Jan 1, 2022
148.71 INR
Jan 1, 2023
-750.33 INR
Jan 1, 2024
-442.06 INR
Jan 1, 2025
-610.53 INR
Jan 1, 2026
-537.53 INR
The Ajooni Biotech FCF Conversion history
YEARFCF ConversionYoY
-537.53 %-11.96%
-610.53 %+38.11%
-442.06 %-41.09%
-750.33 %-604.55%
148.71 %-123.40%
-635.64 %-61.90%
-1,668.28 %+31.79%
-1,265.88 %+1,621.34%
-73.54 %-87.99%
-612.51 %-24.99%
-816.58 %+865.05%
-84.62 %-95.69%
-1,963.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ajooni Biotech Stock analysis

What does Ajooni Biotech do? Ajooni Biotech Ltd, listed on the National Stock Exchange of India with ticker AJOONI.NS and ISIN INE820Y01021, is a company operating in the Consumer Staples sector, specifically within the Food Products industry. Headquartered in Mohali, Punjab, the company went public through an IPO on January 2, 2018. Ajooni Biotech focuses on the manufacturing, production, processing, and supply of cattle feed nutrients and animal health care supplements. The company offers a variety of products including compounded animal feed and feed supplements designed to support the entire life cycle of animals. Its product range encompasses cattle feed, cattle feed chips, camel feed, cotton oil cake, and mustard oil cake. The firm provides high-energy balanced cattle feed formulations such as calf starter, heifer, dairy calf grower, low yield cattle, basic milking cattle, and high yield cattle feeds. Specific product names mentioned include Autus DIAMOND WONDER, Autus NURTURE CALF STARTER, Autus WINNER, Autus HIFFER/GROWER, Autus ENERGY PLUS, Autus ECO, and Autus BUFF POWER. Additionally, the company supplies feed supplements like liquid calcium, liver tonic, mineral mixture, ultra-tonic, digestive powder, and multi vitamins, as well as products such as CALTUS, 4U, LIVTUS, RUMITUS, Mustmin, and AUTOVITA. The company's website is https://www.ajoonibiotech.com/. Ajooni Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ajooni Biotech stock

FCF Conversion Rate (FCF/EBITDA) of Ajooni Biotech is -537.53 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Ajooni Biotech changed from -610.53 % to -537.53 %, representing a -11.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Ajooni Biotech since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Ajooni Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Ajooni Biotech

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Ajooni Biotech